Completed PHASE4 INTERVENTIONAL 4-arm NCT00624559

The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

COX-2 Regulation of Renal Sodium Handling in Blood Pressure Maintenance

Sponsor: Christiana Care Health Services

Interventions Placebo celecoxib (Celebrex)

Updated 7 times since 2017 Last updated: Jan 4, 2012 Started: Feb 29, 2008 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hypertension, this trial is completed. The trial is conducted by Christiana Care Health Services and has accumulated 7 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Christiana Care Health Services
University of Delaware

Data source: University of Delaware

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newark, United States